Fluid Management System for ADHF Diuretic Resistance

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for acute decompensated heart failure (ADHF) patients with excess fluid are inefficient, leading to unpredictable diuretic response, diuretic resistance, and increased risk of pulmonary edema due to intravascular dehydration, which complicates fluid management and kidney function.

Innovation Solution

A fluid management system and method that automatically adjusts hydration fluid infusion rates based on urine output to achieve a desired urine output rate, followed by controlled fluid loss, using a diuretic and potentially hypertonic saline to prevent dehydration and manage fluid overload.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If diuretics are administered to remove excess fluid from ADHF patients, then fluid overload is reduced, but intravascular dehydration occurs leading to diuretic resistance

Engineering Contradiction:
Improveexcess fluid volumeVSAvoiddiuretic response reliability
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The system continuously monitors urine output and automatically adjusts hydration fluid infusion rates based on real-time feedback. When urine output decreases (indicating intravascular depletion), the system increases hydration fluid infusion to prevent further depletion and maintain diuretic responsiveness, creating a closed-loop control system that prevents diuretic resistance

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system proactively administers hydration fluid before severe intravascular depletion occurs by monitoring urine output trends and predicting fluid status. This preliminary action prevents the development of diuretic resistance by maintaining adequate intravascular volume before it becomes critically low

Inventive Principle:
Principle #10Preliminary action

2Productivity

If high doses of diuretics are administered to overcome diuretic resistance, then fluid removal efficiency increases, but kidney damage risk increases due to intravascular depletion

Engineering Contradiction:
Improvefluid removal rateVSAvoidkidney damage
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The system monitors urine output and automatically adjusts both diuretic and hydration fluid infusion rates. When urine output indicates intravascular depletion, the system reduces diuretic dosage and increases hydration fluid infusion, preventing kidney damage while maintaining effective fluid removal through dynamic dose adjustment rather than fixed high dosing

Inventive Principle:
Principle #23Feedback

3Adaptability or versatility

If manual monitoring and adjustment of fluid therapy is performed, then treatment flexibility is maintained, but treatment accuracy and responsiveness are reduced

Engineering Contradiction:
Improvetreatment flexibilityVSAvoidfluid balance control accuracy
Core Design Contradiction:
Adaptability or versatilityVSMeasurement precision

Solution Approach 1:

The system automatically monitors urine output, calculates fluid balance, and adjusts infusion rates without requiring continuous manual intervention. This self-service capability maintains treatment flexibility through programmable parameters while achieving superior measurement precision and responsiveness through continuous automated monitoring and adjustment

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The closed-loop system continuously monitors urine output and automatically adjusts fluid therapy parameters, providing precise real-time control that exceeds manual monitoring capabilities while maintaining flexibility through programmable treatment protocols and adjustable parameters

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS20230414871A1Fluid therapy method
Publication Date: 2023.12.28 REPRIEVE CARDIOVASCULAR INC
  • US20230414871A1 patent drawing
  • US20230414871A1 patent drawing
  • US20230414871A1 patent drawing

AI summary

A fluid therapy method for an ADHF patient includes setting a urine output rate desired threshold, setting one or more desired negative net gain rates, and optionally setting a total fluid loss goal. The urine output of the patient is monitored and fluid is automatically administered to the patient at increasing rates to equal to or approximately match the patient's increasing urine output rates until the patient's urine output rate reaches the set urine output rate desired threshold. Thereafter, fluid is administered to the patient at rates to achieve the set desired negative net gain rate until the fluid loss goal is reached. Thereafter, until the end of therapy, fluid is administered to the patient at rates equal to or approximately equal to the monitored urine output rates.